Add Yahoo as a preferred source to see more of our stories on Google. If angina pectoris – pain, pressure or tightness and shortness of breath – suddenly occurs even at rest, this can indicate an ...
Patients who have received at least one COVID-19 vaccine dose after acute coronary syndromes do not have a reduced risk for cardiovascular events, according to a research letter published online May ...
Chronic angina is a major medical problem in the United States with more than 6 million patients affected, a number that will increase substantially because of the progressive aging of the population.
BECAUSE angina pectoris is a consequence of inadequate myocardial oxygenation, ideal therapy for this incapacitating symptom would be directed toward both increasing coronary blood flow and decreasing ...
When a robust man suddenly drops dead and the newspapers report “heart failure,” the probability is that he died during an attack of angina pectoris. If he had gone to his doctor the day before, the ...
A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels - thereby reducing the risk of heart attack or stroke ...
The most recent data comes from the Efficacy of Ranolazine in Chronic Angina (ERICA) trial, published in the August 1, 2006, issue of JACC. 17 Stable patients with coronary disease and ≥3 anginal ...
A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels -- thereby reducing the risk of heart attack or ...
DURING the past two years, interest in the use of vitamin E in the treatment of various forms of heart disease has been aroused by several reports of its efficacy appearing in medical and nonmedical ...
The diagnosed prevalent cases of angina pectoris is expected to increase from 19.58 million cases in 2018 to 22.79 million cases in 2028, at an annual growth rate (AGR) of 1.64% across the seven major ...
Patients who have received at least one COVID-19 vaccine dose after acute coronary syndromes do not have a reduced risk for cardiovascular events, according to a research letter published online May ...